3SBio Signs Deal For Isotechnika's Transplant/Immune System Drug Voclosporin
This article was originally published in The Pink Sheet Daily
Executive Summary
The deal was announced less than three weeks after U.S. FDA requested an additional Phase III trial for an oral voclosporin used in uveitis therapy.